|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.10 USD | +1.96% |
|
-0.35% | -25.42% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.08B | - | - | |||
| 983B | |||||
| 557B | |||||
| 406B | |||||
| 314B | |||||
| 273B |
Select your edition
All financial news and data tailored to specific country editions
